1. Home
  2. SMWB vs ARMP Comparison

SMWB vs ARMP Comparison

Compare SMWB & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Similarweb Ltd.

SMWB

Similarweb Ltd.

HOLD

Current Price

$4.39

Market Cap

300.5M

Sector

Technology

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$7.87

Market Cap

295.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMWB
ARMP
Founded
2007
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
300.5M
295.5M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
SMWB
ARMP
Price
$4.39
$7.87
Analyst Decision
Hold
Strong Buy
Analyst Count
6
2
Target Price
$4.00
$15.00
AVG Volume (30 Days)
928.6K
63.8K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.07
N/A
Revenue Next Year
$11.17
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$1.74
52 Week High
$10.75
$14.98

Technical Indicators

Market Signals
Indicator
SMWB
ARMP
Relative Strength Index (RSI) 71.46 41.35
Support Level $2.44 $7.22
Resistance Level $7.82 $7.93
Average True Range (ATR) 0.32 0.81
MACD 0.05 0.04
Stochastic Oscillator 83.91 43.72

Price Performance

Historical Comparison
SMWB
ARMP

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: